These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Experience with cefuroxime in 190 patients with severe respiratory infections.
    Author: Pines A, Raafat H, Kennedy MR, Mullinger BM.
    Journal: Chemotherapy; 1980; 26(3):212-7. PubMed ID: 7363715.
    Abstract:
    Cefuroxime is a very effective agent for the treatment of severe purulent respiratory infections. 190 patients with purulent exacerbations of bronchitis or bronchiectasis, pneumonia or secondarily infected lung cancer received 2.25--3.0 g cefuroxime daily for an average of 9 days. A good clinical response was seen in 91% of 184 assessable patients. A remarkable improvement in sputum purulence was observed and side-effects to cefuroxime were minimal.
    [Abstract] [Full Text] [Related] [New Search]